Q&A

Making The Medicines Of The Future

Source: Pall Biotech

With Tony Hitchcock, Technical Director of Cobra Biologics

Cells_450x300

Only a small number of cell and gene therapies have been approved to date by the FDA or EMA, but there is a great deal of excitement in the area. Not only are phenomenal advances being seen in science and discovery, but new developments in manufacturing equipment are making the commercial production of the resulting therapies a reality. According to Tony Hitchcock, single-use has been a key enabler of the cell and gene therapy manufacturing industry.